Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (20,850)	$ (13,216)	$ (9,038)	$ (9,038)	$ (34,068)	$ (18,075)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation & amortization					1,292	28
Accretion of discount on available-for-sale securities					(398)	0
Stock-based compensation					8,277	7,735
Amortization of debt discount					0	1,678
Change in fair value of derivative liability					0	222
Changes in operating assets and liabilities, net of effects of business acquired:
Accounts receivable					(499)	(90)
Inventory					0	65
Prepaid expenses					(650)	(443)
Other receivables					(283)	(180)
Accounts payable					(485)	(663)
Accrued liabilities					1,208	(121)
Deferred revenue					(8)	53
Operating lease liabilities, net					188	(29)
Net cash used in operating activities					(25,426)	(9,820)
Cash flows from investing activities:
Purchases of property and equipment					(9,498)	(798)
Purchases of short-term marketable securities					(66,308)	0
Security deposits					(69)	0
Acquisition, net of cash acquired					(5,634)	0
Capitalized software					(425)	0
Net cash used in investing activities					(81,934)	(798)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs					75,847	35,849
Proceeds from issuance of common stock under the 2025 Equity Distribution Agreement, net of offering costs					13,521	0
Proceeds from exercise of warrants					11,376	6
Proceeds from exercise of options					224	9
Proceeds from short-swing profit disgorgement					48	0
Payments of deferred offering costs					(35)	0
Repayment of financing lease liability					(186)	(747)
Proceeds from convertible notes payable, net of offering costs					0	4,845
Repayments of notes payable, related party					0	(70)
Repayments of note payable					0	(500)
Net cash provided by financing activities					100,795	39,392
Effect of exchange rate changes on cash and cash equivalents					(1)	0
Net change in cash and cash equivalents					(6,565)	28,774
Cash and cash equivalents at beginning of period		$ 123,266		$ 7	123,266	7	$ 7
Cash and cash equivalents at end of period	$ 116,700		$ 28,781		116,700	28,781	$ 123,266
Supplemental disclosure of cash flow information:
Cash paid for income taxes					0	0
Cash paid for interest					93	50
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid					64	0
Conversion of convertible notes and derivative into common stock					$ 0	$ 6,804